Ideal cardiovascular health is inversely associated with non-alcoholic fatty liver disease: a prospective analysis
Non-alcoholic fatty liver disease (NAFLD) is one of the most important causes of liver diseases worldwide with a global prevalence currently estimated to be 24% and will probably emerge as the leading cause of end-stage liver disease in the coming decades.1-3 In addition to progression into nonalcoholic steatohepatitis (NASH), cirrhosis, and liver carcinoma,4 NAFLD has also been proved to be independently associated with cardiovascular disease, chronic kidney disease, type 2 diabetes, neoplasms, and other extrahepatic diseases.
Source: The American Journal of Medicine - Category: General Medicine Authors: Long Wang, Mian Li, Zhiyun Zhao, Min Xu, Jieli Lu, Tiange Wang, Yuhong Chen, Shuangyuan Wang, Meng Dai, Yanan Hou, Xueyan Wu, Lina Ma, Lin Li, Shanshan Liu, Weiqing Wang, Yu Xu, Yufang Bi, Guang Ning Tags: Clinical Research Study Source Type: research
More News: Alcoholism | Cancer & Oncology | Carcinoma | Cardiology | Cardiovascular | Chronic Kidney Disease | Cirrhosis | Diabetes | Diabetes Type 2 | Endocrinology | Fatty Liver Disease (FLD) | General Medicine | Heart | Hepatocellular Carcinoma | Liver | Liver Cancer | Liver Disease | Men | Non-alcoholic Fatty Liver Diseases (NAFLD) | Study | Urology & Nephrology